Insider Transactions in Q3 2021 at Nabriva Therapeutics PLC (NBRV)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2021
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
63
-0.02%
|
$63
$1.19 P/Share
|
|
Sep 30
2021
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
107
-0.05%
|
$107
$1.19 P/Share
|
|
Sep 14
2021
|
Theodore R Schroeder Director |
BUY
Open market or private purchase
|
Direct |
50,000
+18.06%
|
$50,000
$1.13 P/Share
|
|
Sep 06
2021
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
93
-0.03%
|
$93
$1.11 P/Share
|
|
Sep 06
2021
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
225
-0.13%
|
$225
$1.11 P/Share
|
|
Aug 31
2021
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
37
-0.09%
|
$37
$1.06 P/Share
|
|
Aug 31
2021
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
107
-0.06%
|
$107
$1.06 P/Share
|
|
Aug 31
2021
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
63
-0.02%
|
$63
$1.06 P/Share
|
|
Aug 06
2021
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
74
-0.18%
|
$74
$1.17 P/Share
|
|
Aug 06
2021
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
92
-0.03%
|
$92
$1.17 P/Share
|
|
Aug 06
2021
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
225
-0.13%
|
$225
$1.17 P/Share
|
|
Aug 02
2021
|
Carrie L. Bourdow Director |
SELL
Open market or private sale
|
Direct |
777
-4.04%
|
$777
$1.2 P/Share
|
|
Aug 02
2021
|
Charles A Rowland Jr Director |
SELL
Open market or private sale
|
Direct |
777
-3.17%
|
$777
$1.2 P/Share
|
|
Aug 02
2021
|
Colin Md Broom Director |
SELL
Open market or private sale
|
Direct |
531
-1.25%
|
$531
$1.2 P/Share
|
|
Aug 02
2021
|
Daniel D Burgess Director |
SELL
Open market or private sale
|
Direct |
1,125
-4.92%
|
$1,125
$1.2 P/Share
|
|
Aug 02
2021
|
Stephen W Webster Director |
SELL
Open market or private sale
|
Direct |
777
-3.88%
|
$777
$1.2 P/Share
|
|
Jul 31
2021
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
37
-0.09%
|
$37
$1.1 P/Share
|
|
Jul 31
2021
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
63
-0.02%
|
$63
$1.1 P/Share
|
|
Jul 31
2021
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
107
-0.06%
|
$107
$1.1 P/Share
|
|
Jul 28
2021
|
Lisa Dalton Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+50.0%
|
-
|
|
Jul 28
2021
|
Mark Corrigan Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+50.0%
|
-
|
|
Jul 28
2021
|
Stephen W Webster Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+46.6%
|
-
|
|
Jul 28
2021
|
Carrie L. Bourdow Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+47.62%
|
-
|
|
Jul 28
2021
|
Charles A Rowland Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+41.62%
|
-
|
|
Jul 28
2021
|
Colin Md Broom Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+29.22%
|
-
|
|
Jul 28
2021
|
Daniel D Burgess Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+43.37%
|
-
|
|
Jul 06
2021
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
74
-0.18%
|
$74
$1.27 P/Share
|
|
Jul 06
2021
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
92
-0.03%
|
$92
$1.27 P/Share
|
|
Jul 06
2021
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
225
-0.13%
|
$225
$1.27 P/Share
|